Cargando…

Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials

Objective To define the cardiovascular effects of lowering blood pressure in people with chronic kidney disease. Design Collaborative prospective meta-analysis of randomised trials. Data sources and eligibility Participating randomised trials of drugs to lower blood pressure compared with placebo or...

Descripción completa

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789583/ https://www.ncbi.nlm.nih.gov/pubmed/24092942 http://dx.doi.org/10.1136/bmj.f5680

Ejemplares similares

Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis
por: Nazarzadeh, Milad, et al.
Publicado: (2022)

Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials
por: Heerspink, Hiddo J Lambers, et al.
Publicado: (2009)

Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status
por: Currie, Craig J., et al.
Publicado: (2019)

Association Between Systolic Blood Pressure Variability and Major Adverse Cardiovascular Events in Korean Patients With Chronic Kidney Disease: Findings From KNOW‐CKD
por: Park, Cheol Ho, et al.
Publicado: (2022)

The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis
por: Jardine, Meg J, et al.
Publicado: (2012)

Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials
Publicado: (2010)

Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials
por: De Berardis, Giorgia, et al.
Publicado: (2009)

Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis
por: Pinho-Gomes, Ana-Catarina, et al.
Publicado: (2021)

The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials
por: Brugts, J J, et al.
Publicado: (2009)

How Much Lowering of Blood Pressure Is Required to Prevent Cardiovascular Disease in Patients With and Without Previous Cardiovascular Disease?
por: Canoy, Dexter, et al.
Publicado: (2022)

Risk of Major Cardiovascular Events in People with Down Syndrome
por: Sobey, Christopher G., et al.
Publicado: (2015)

Urine Klotho Is Lower in Critically Ill Patients With Versus Without Acute Kidney Injury and Associates With Major Adverse Kidney Events
por: Neyra, Javier A., et al.
Publicado: (2019)

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
por: Law, M R, et al.
Publicado: (2009)

Vitamin D supplementation and major cardiovascular events: D-Health randomised controlled trial
por: Thompson, Bridie, et al.
Publicado: (2023)

Effectiveness of lipid-lowering therapy on mortality and major adverse cardiovascular event outcomes in patients undergoing percutaneous coronary intervention: a network meta-analysis of randomised controlled trials
por: Deng, Chang-Jiang, et al.
Publicado: (2023)

Long‐Term Blood Pressure Variability and Major Adverse Cardiovascular and Cerebrovascular Events After Intracerebral Hemorrhage
por: Castello, Juan Pablo, et al.
Publicado: (2022)

Ascorbic acid lowers central blood pressure and asymmetric dimethylarginine in chronic kidney disease
por: Gillis, Keith, et al.
Publicado: (2018)

Feasibility of a structured group education session to improve self-management of blood pressure in people with chronic kidney disease: an open randomised pilot trial
por: Byrne, Jo, et al.
Publicado: (2011)

Impact of interankle blood pressure difference on major adverse cardiovascular events in cryptogenic stroke patients without peripheral artery disease: a retrospective cohort study
por: Han, Minho, et al.
Publicado: (2022)

Serum Phosphate as a Risk Factor for Cardiovascular Events in People with and without Chronic Kidney Disease: A Large Community Based Cohort Study
por: McGovern, Andrew Peter, et al.
Publicado: (2013)

Benefits and harms of lower blood pressure treatment targets: systematic review and meta-analysis of randomised placebo-controlled trials
por: Brunström, Mattias, et al.
Publicado: (2019)

Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trial
por: Mostaza, José M., et al.
Publicado: (2022)

Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data
por: Karmali, Kunal N., et al.
Publicado: (2018)

Association between admission systolic blood pressure and major adverse cardiovascular events in patients with acute myocardial infarction
por: Pei, Junyu, et al.
Publicado: (2020)

Early Major Adverse Cardiovascular Event in a Patient With Chronic Kidney Disease: A Case Report
por: Saleh Juman Alseiari, Saleh, et al.
Publicado: (2023)

Residual Cardiovascular Risk in Individuals on Blood Pressure–Lowering Treatment
por: Lieb, Wolfgang, et al.
Publicado: (2015)

Nationwide Study on Trends in Hospital Admissions for Major Cardiovascular Events and Procedures Among People With and Without Diabetes in England, 2004–2009
por: Vamos, Eszter P., et al.
Publicado: (2012)

Ten-year predictors of major adverse cardiovascular events in patients without angina
por: Premsagar, Preesha, et al.
Publicado: (2023)

Effects of Intensive Blood Pressure Lowering on Cardiovascular and Renal Outcomes: A Systematic Review and Meta-Analysis
por: Lv, Jicheng, et al.
Publicado: (2012)

The effect of lowering salt intake on ambulatory blood pressure to reduce cardiovascular risk in chronic kidney disease (LowSALT CKD study): protocol of a randomized trial
por: McMahon, Emma J, et al.
Publicado: (2012)

Association of uncontrolled blood pressure in apparent treatment‐resistant hypertension with increased risk of major adverse cardiovascular events plus
por: Bakris, George, et al.
Publicado: (2023)

Baseline and Cumulative Blood Pressure in Predicting the Occurrence of Cardiovascular Events
por: Zuo, Yingting, et al.
Publicado: (2021)

Prediction of cardiovascular events from systolic or diastolic blood pressure
por: Talebi, Atefeh, et al.
Publicado: (2022)

Association of Blood Pressure and Risk of Cardiovascular and Chronic Kidney Disease in Hong Kong Hypertensive Patients
por: Wan, Eric Yuk Fai, et al.
Publicado: (2019)

Comparative review of the blood pressure-lowering and cardiovascular benefits of telmisartan and perindopril
por: Wang, Ji-Guang, et al.
Publicado: (2014)

Blood pressure management in hypertensive people with non-dialysis chronic kidney disease in Queensland, Australia
por: Zhang, Jianzhen, et al.
Publicado: (2019)

Effect of blood pressure lowering medications on leg ischemia in peripheral artery disease patients: A meta-analysis of randomised controlled trials
por: Thomas Manapurathe, Diana, et al.
Publicado: (2017)

Effect of salt reduction interventions in lowering blood pressure in Chinese populations: a systematic review and meta-analysis of randomised controlled trials
por: Jin, Aoming, et al.
Publicado: (2020)

Gender differences in hospital admissions for major cardiovascular events and procedures in people with and without diabetes in England: a nationwide study 2004–2014
por: Laverty, Anthony A., et al.
Publicado: (2017)

Results and lessons from the Spironolactone To Prevent Cardiovascular Events in Early Stage Chronic Kidney Disease (STOP-CKD) randomised controlled trial
por: Ng, Khai P, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ro02865q7muna7e3n5qh7d67bh